[
  {
    "ts": "2025-10-15T21:45:05+00:00",
    "headline": "AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know",
    "summary": "The latest trading day saw AbbVie (ABBV) settling at $226.22, representing a -1.27% change from its previous close.",
    "url": "https://finance.yahoo.com/news/abbvie-abbv-stock-falls-amid-214505696.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ebd8f1bb-2de1-3140-816a-6a4c04219f85",
      "content": {
        "id": "ebd8f1bb-2de1-3140-816a-6a4c04219f85",
        "contentType": "STORY",
        "title": "AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know",
        "description": "",
        "summary": "The latest trading day saw AbbVie (ABBV) settling at $226.22, representing a -1.27% change from its previous close.",
        "pubDate": "2025-10-15T21:45:05Z",
        "displayTime": "2025-10-15T21:45:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/2f0d6efdd8740952a371c97ddea6e926",
          "originalWidth": 900,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y.YEouD16bNWn6FshAyysg--~B/aD02MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2f0d6efdd8740952a371c97ddea6e926.cf.webp",
              "width": 900,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sqqoypFHTaqTKxA9xCsU7A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/2f0d6efdd8740952a371c97ddea6e926.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-stock-falls-amid-214505696.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-abbv-stock-falls-amid-214505696.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^IXIC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-15T12:30:13+00:00",
    "headline": "Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal",
    "summary": "Investing.com -- Enveric Biosciences (NASDAQ: ENVB) has hired prominent intellectual property law firm Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals, which earlier this year agreed to be acquired by AbbVie for up to $1.2 billion, Investing.com has learned.",
    "url": "https://finance.yahoo.com/news/enveric-biosciences-hires-fish-richardson-123013625.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "b5de9404-b2bb-349d-85a1-ef521d075e42",
      "content": {
        "id": "b5de9404-b2bb-349d-85a1-ef521d075e42",
        "contentType": "STORY",
        "title": "Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal",
        "description": "",
        "summary": "Investing.com -- Enveric Biosciences (NASDAQ: ENVB) has hired prominent intellectual property law firm Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals, which earlier this year agreed to be acquired by AbbVie for up to $1.2 billion, Investing.com has learned.",
        "pubDate": "2025-10-15T12:30:13Z",
        "displayTime": "2025-10-15T12:30:13Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/enveric-biosciences-hires-fish-richardson-123013625.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/enveric-biosciences-hires-fish-richardson-123013625.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "ENVB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-15T12:00:00+00:00",
    "headline": "Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal",
    "summary": "CAMBRIDGE, Mass., October 15, 2025--Enveric Biosciences (NASDAQ: ENVB) (\"Enveric\" or the \"Company\"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it has hired intellectual property powerhouse Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals (Gilgamesh) against Enveric’s issued U.S. Patent No. 12,138,276 (the’276 patent,) entitled,",
    "url": "https://finance.yahoo.com/news/enveric-biosciences-hires-ip-powerhouse-120000294.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "0affc028-4ab5-306b-9c3a-3f9a668e4dff",
      "content": {
        "id": "0affc028-4ab5-306b-9c3a-3f9a668e4dff",
        "contentType": "STORY",
        "title": "Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal",
        "description": "",
        "summary": "CAMBRIDGE, Mass., October 15, 2025--Enveric Biosciences (NASDAQ: ENVB) (\"Enveric\" or the \"Company\"), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced that it has hired intellectual property powerhouse Fish and Richardson P.C. to contest a Post-Grant Review (PGR) petition filed by Gilgamesh Pharmaceuticals (Gilgamesh) against Enveric’s issued U.S. Patent No. 12,138,276 (the’276 patent,) entitled,",
        "pubDate": "2025-10-15T12:00:00Z",
        "displayTime": "2025-10-15T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/78c9c50a2c74bf45c2da9e1bd9607b84",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F1t4aumWdohFkBxU6bXYqQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/78c9c50a2c74bf45c2da9e1bd9607b84.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4tcHcusl12ZVcotCiBSp2w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/78c9c50a2c74bf45c2da9e1bd9607b84.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/enveric-biosciences-hires-ip-powerhouse-120000294.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/enveric-biosciences-hires-ip-powerhouse-120000294.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ENVB"
            },
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]